Viewing Regenica Biosciences, Inc. - University of California 3rd Annual Pitch Competition

Jack Fernandes

Alumni of UC Los Angeles (Professional)

Regenica Biosciences, Inc.

Regenica Biosciences, Inc. operates as a hybrid between a clinical stage pharmaceutical company and a government defense contractor. Regenica specializes in the development and commercialization of solutions for serious unmet medical needs and biothreats. Regenica has developed a regulatory strategy that allows for the economically feasible development of historically unprofitable but high social need drugs and vaccines. Regenica is currently seeking FDA approval on an antidote to nerve agent exposure designed to treat any immediate organophosphate toxicity throughout the brain and body while preventing the persisting seizures that recur following exposure.



Primary Industry Sector: Medical Therapeutics
Funding Status: Preseed

514

fernandes2019@lawnet.ucla.edu

Preseed

Medical Therapeutics

Law School, J.D.

Share this on